Halper Sadeh LLC is investigating whether Kyverna Therapeutics' officers and directors breached their fiduciary duties to shareholders. Long-term shareholders of Kyverna stock may be entitled to seek corporate governance reforms, financial awards, or other relief. The law firm offers free consultations and works on a contingency fee basis, encouraging shareholders to act quickly due to potential time limits. Shareholder involvement could lead to improved company oversight and increased shareholder value.
Kyverna Therapeutics fiduciary duty concerns come amid a Health-sector market where 111 of 150 US stocks fell on November 12, 2026, at 23:11 WIB. For readers following Health-sector stocks, here is Pluang's market snapshot as of that time: Aveanna Healthcare Holdings Inc. (AVAH) dropped 6.04% to USD 12.30 with a typical hold time of 25 days, ImmunityBio Inc. (IBRX) fell 6.00% to USD 6.27 with a 3-day hold, and Canopy Growth Corp (CGC) declined 5.80% to USD 0.57 with a 40-day hold and a Pluang order activity of 1% Sell / 99% Buy.
TRM Labs introduced the Disruption Awards to recognize coalitions of public and private organizations that successfully disrupted major cybercrimes in 2026. Winners include groups that took down a phishing service responsible for most Microsoft-block...
Existing-home sales in the U.S. dropped 5.5% month-over-month and 8.8% year-over-year in October, reaching the lowest level since August 2010. The decline is attributed to mortgage rates rising to their highest since 2000, making home buying more dif...
The global specialty zeolites market, valued at $1 million in 2025, is projected to reach $1.5 million by 2032 with a 5.8% CAGR. Growth is fueled by stricter environmental regulations and rising demand in water treatment, petrochemicals, agriculture,...
The global cell lysis and cell fractionation market, valued at $2.8 billion in 2025, is projected to grow to $4.5 billion by 2032 at a 7% CAGR. Growth is fueled by advances in biotechnology, increased life sciences research investments, and rising de...
atQor has been named a finalist for the 2026 Microsoft Partner of the Year Award in the Agents category, recognized for its innovative and scalable agentic AI solutions deployed across nine industries. The company developed 252 AI agents in FY26, wit...
